MERCK-MILLIPORE
Merck Millipore, the Life Science division of Merck, announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2014. The 52nd Annual R&D Awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.
“A key component of our strategy is to offer the highest quality and most innovative products. Recognition for two R&D Magazine awards exemplifies our technical expertise and leadership in providing differentiated solutions to a broad range of customers across the life science industry,” said Udit Batra, President and Chief Executive Officer of Merck Millipore. “In 2013, Merck Millipore invested €160 million in R&D activities, and we will continue to support efforts to drive future advancements in our portfolio of offerings. We are most appreciative of those employees who have dedicated their careers to furthering scientific advancement in these fields.”
The Merck Millipore products that were recognized are:
- The SmartFlare™ detection reagent is a novel probe capable of detecting specific mRNAs and miRNAs in live, intact cells. This technology allows for carrier-free cellular endocytosis of the reagent, followed by detection and relative quantitative analysis of RNA levels. Because the reagent leaves the cell after the detection event, the same sample can be used for any downstream analysis, meaning you can assess multiple biomarkers or downstream functionalities in the same cells.
- Clarisolve ® depth filters are specifically tuned to the particle size distribution of various pretreatment methodologies enabling the fastest and most efficient way to clarify high-density streams and easily transfer processes from upstream to downstream without the use of centrifugation. Clarisolve depth filters were designed for high cell density/titer mammalian cell culture feed streams for mAb production. There has also been early success in microbial and vaccine applications.
With nearly 800 employees focused on R&D, Merck Millipore is working with customers to develop innovative solutions for the research, development and production of biopharmaceuticals and biotech processes worldwide.
Widely regarded as the “Oscars of Invention”, the R&D 100 Awards identify and celebrate the top technology products of the year. Past winners have included sophisticated testing equipment, innovative new materials, chemistry breakthroughs, biomedical products, consumer items, and high-energy physics. The R&D 100 Awards spans industry, academia, and government-sponsored research.
The winners of the R&D 100 Awards are selected by an independent judging panel and the editors of R&D Magazine.
About Merck Millipore
Merck Millipore is the Life Science
division of Merck and offers a broad range of innovative, performance
products, services and business relationships that enable our customers’
success in research, development and production of biotech and
pharmaceutical drug therapies. Through dedicated collaboration on new
scientific and engineering insights, and as one of the top three R&D
investors in the Life Science Tools industry, Merck Millipore serves as
a strategic partner to customers and helps advance the promise of life
science. Headquartered in Billerica, Massachusetts, the division has
around 10,000 employees, operations in 66 countries and 2013 revenues of
€2.6 billion Merck Millipore operates as EMD Millipore in the U.S. and
Canada.
About Merck
Merck is a leading company for innovative and
top-quality high-tech products in the pharmaceutical and chemical
sectors. With its four divisions Merck Serono, Consumer Health,
Performance Materials and Merck Millipore, Merck generated total
revenues of €11.1 billion in 2013. Around 39,000 Merck employees work in
66 countries to improve the quality of life for patients, to further the
success of customers and to help meet global challenges. Merck is the
world’s oldest pharmaceutical and chemical company – since 1668, the
company has stood for innovation, business success and responsible
entrepreneurship. Holding an approximately 70 percent interest, the
founding family remains the majority owner of the company to this day.
Merck, Darmstadt, Germany is holding the global rights to the Merck name
and brand. The only exceptions are Canada and the United States, where
the company is known as EMD.
About R&D Magazine
Since its founding in 1959 as Industrial
Research
, R&D Magazine
has served research
scientists, engineers and technical staff at laboratories around the
world, providing timely, informative news and useful technical articles
that broaden readers’ knowledge of the research and development industry
and improve the quality of their work. R&D Magazine
is a
publication of Advantage Business Media (www.advantagebusinessmedia.com
).
Contact:
Susan Alesina, 978-715-4622
susan.alesina@emdmillipore.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Ant International’s WorldFirst Accelerates SEA Growth with Malaysia MSB Licence7.8.2025 09:04:00 CEST | Press release
Ant International receives Bank Negara Malaysia Class A Money Services Business licence for WorldFirst to operate cross-border payment services.This new licence strengthens WorldFirst’s product and service offerings for businesses expanding into and out of Malaysia.The licence adds to WorldFirst’s portfolio of over 60 licences across Asia, Europe, North America and Oceania. Ant International has obtained approval from Bank Negara Malaysia to carry out business under a Class A Money Services Business licence. The licence will empower Ant International’s WorldFirst—an all-in-one digital cross-border payment and treasury account service for global businesses—to operate in Malaysia, adding to its 60+ global licences worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806541491/en/ WorldFirst's All-in-One Business Account for Global Payments The licence will enable WorldFirst to expand its product offerings and roll out
Objectway Accelerates Its Growth Path Through an Investment From Cinven in Partnership With Its Founder Luigi Marciano and the Existing Management Team7.8.2025 09:00:00 CEST | Press release
The majority investment marks the start of a new phase of growth for Objectway, leveraging its resilient and scalable business model, its end-to-end solution-as-a-service platform, and long-term partnerships with a blue-chip customer base. Luigi Marciano, founder of Objectway, a leading provider of software and services to financial institutions across Europe, North America and the Middle East, along with Objectway’s management team and international private equity firm, Cinven, today announced an agreement under which Cinven will make a majority investment in Objectway. Luigi Marciano will remain a significant shareholder alongside Cinven, and continue in his role as CEO and Chair. He and his existing management team will continue to manage the business, and Cinven’s backing will provide strategic and financial support, including continued investment in technology innovation, as well as support for future organic growth and targeted M&A opportunities. Together, Luigi Marciano, his tea
Art Collective teamLab to Open New Museum, teamLab Biovortex Kyoto on October 7, 20257.8.2025 08:00:00 CEST | Press release
Unveiling 7 artworks, including pieces never before exhibited in Japan. Tickets on Sale now teamLab Biovortex Kyoto, art collective teamLab’s permanent art museum, is set to open in Minami-ku, Kyoto, as part of the Kyoto Station Southeast Area Project on October 7, 2025. This will be teamLab's largest museum in Japan, spanning over 10,000 square meters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806347101/en/ Even if individual elements are separated in space and time, when a structural order appears among them, the elements transcend space and time and form a single entity. Despite significant changes in shape or size on the surface, or even if all of the elements are replaced, the single existence will be maintained. This spatiotemporal existence is part of the whole, it appears from the whole, and is returned to it. It is a living universe - a biocosmos. (teamLab, Morphing Continuum © teamLab) In preparation for th
Allianz Announces Excellent Performance and Is Fully on Track for Full-year Ambitions7.8.2025 07:13:00 CEST | Press release
2Q 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806235547/en/ Oliver Bäte, Chief Executive Officer of Allianz SE Allianz achieves strong growth and record operating profitTotal business volume rises 8.01 percent to 44.5 billion euros, supported by good growth across all segments Operating profit increases 12.2 percent and reaches a record level of 4.4 billion euros, with particular strong contribution from the Property-Casualty segment Shareholders’ core net income advances by 17.3 percent and reaches 3.0 billion euros. Adjusted for the 0.3 billion euros disposal gain on the UniCredit Joint Venture, shareholders’ core net income increases 7.1 percent 6M 2025 Excellent performance across our businesses and record operating profitTotal business volume grows 10.1 1 percent and reaches 98.5 billion euros, with contributions from all segments Operating profit increases 9.3 percent to 8.6 billion euros, our highest half-
New pulp mill boosts Suzano's sales and revenue in the second quarter of 20257.8.2025 04:17:00 CEST | Press release
Suzano, the world’s largest pulp producer, announces its results for the second quarter of 2025 (2Q25), reporting sales of 3.7 million tonnes of pulp and paper. Sales increased 28% over the same period in 2024 (2Q24), mainly reflecting the strong operational contribution of the new Ribas do Rio Pardo pulp mill, whose production started in July 2024. Net revenue in the quarter totaled R$13.3 billion, a 16% increase compared to 2Q24. The expansion of pulp production capacity in Brazil, combined with the positive contribution to paper sales from the mills recently acquired in the United States and favorable FX rates, mitigated the impact on net revenue of lower pulp prices in the global market compared to 2Q24. As a result, Suzano's adjusted EBITDA reached R$6.1 billion and operating cash generation totaled R$4.1 billion. Net profit totaled R$5.0 billion positively impacted by the accounting impact of US dollar denominated debt and hedging operations translating into Brazilian Real. Beto
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum